ADUS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 44 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ADUS's RSI Oscillator exited the oversold zone, 17 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ADUS as a result. In 63 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for ADUS just turned positive on October 08, 2026. Looking at past instances where ADUS's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 211 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for ADUS crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
ADUS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ADUS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.918) is normal, around the industry mean (204.137). P/E Ratio (20.336) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (1.483) is also within normal values, averaging (2.688).
The RSI Indicator for HCSG moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In 28 of the 38 cases the stock moved higher. This puts the odds of a move higher at 74%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on HCSG as a result. In 55 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for HCSG just turned positive on October 06, 2026. Looking at past instances where HCSG's MACD turned positive, the stock continued to rise in 29 of 45 cases over the following month. The odds of a continued upward trend are 64%.
HCSG moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCSG advanced for three days, in 196 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
HCSG broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HCSG entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.872) is normal, around the industry mean (204.137). P/E Ratio (12.549) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (1.359) is also within normal values, averaging (2.498). Dividend Yield (0.040) settles around the average of (0.095) among similar stocks. P/S Ratio (0.840) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. HCSG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCSG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
ADUS | HCSG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 59 | 100 | |
SMR RATING 1..100 | 72 | 39 | |
PRICE GROWTH RATING 1..100 | 45 | 49 | |
P/E GROWTH RATING 1..100 | 70 | 96 | |
SEASONALITY SCORE 1..100 | 7 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCSG's Valuation (14) in the Servicestothe Health Industry industry is somewhat better than the same rating for ADUS (76) in the Medical Or Nursing Services industry. This means that HCSG’s stock grew somewhat faster than ADUS’s over the last 12 months.
ADUS's Profit vs Risk Rating (59) in the Medical Or Nursing Services industry is somewhat better than the same rating for HCSG (100) in the Servicestothe Health Industry industry. This means that ADUS’s stock grew somewhat faster than HCSG’s over the last 12 months.
HCSG's SMR Rating (39) in the Servicestothe Health Industry industry is somewhat better than the same rating for ADUS (72) in the Medical Or Nursing Services industry. This means that HCSG’s stock grew somewhat faster than ADUS’s over the last 12 months.
ADUS's Price Growth Rating (45) in the Medical Or Nursing Services industry is in the same range as HCSG (49) in the Servicestothe Health Industry industry. This means that ADUS’s stock grew similarly to HCSG’s over the last 12 months.
ADUS's P/E Growth Rating (70) in the Medical Or Nursing Services industry is in the same range as HCSG (96) in the Servicestothe Health Industry industry. This means that ADUS’s stock grew similarly to HCSG’s over the last 12 months.
| ADUS | HCSG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 77% | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 65% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 67% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 66% |
| Advances ODDS (%) | 11 days ago 66% | 2 days ago 68% |
| Declines ODDS (%) | 4 days ago 63% | 4 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 56% | 2 days ago 71% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADUS’s FA Score shows that 0 FA rating(s) are green while HCSG’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADUS’s TA Score shows that 5 TA indicator(s) are bullish while HCSG’s TA Score has 5 bullish TA indicator(s).
ADUS (@Hospital/Nursing Management) experienced а +1.14% price change this week, while HCSG (@Hospital/Nursing Management) price change was +3.28% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.54%. For the same industry, the average monthly price growth was -3.61%, and the average quarterly price growth was +21.46%.
ADUS is expected to report earnings on Nov 03, 2026.
HCSG is expected to report earnings on Feb 17, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with PNTG. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then PNTG could also see price increases.
| Ticker / NAME | Correlation To ADUS | 1D Price Change % | ||
|---|---|---|---|---|
| ADUS | 100% | -0.07% | ||
| PNTG - ADUS | 40% Loosely correlated | -1.06% | ||
| ENSG - ADUS | 37% Loosely correlated | -1.51% | ||
| NHC - ADUS | 35% Loosely correlated | -4.98% | ||
| HCSG - ADUS | 32% Poorly correlated | +0.98% | ||
| FMS - ADUS | 32% Poorly correlated | +0.70% | ||
More | ||||
A.I.dvisor indicates that over the last year, HCSG has been loosely correlated with NHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HCSG jumps, then NHC could also see price increases.
| Ticker / NAME | Correlation To HCSG | 1D Price Change % | ||
|---|---|---|---|---|
| HCSG | 100% | +0.98% | ||
| NHC - HCSG | 46% Loosely correlated | -4.98% | ||
| ADUS - HCSG | 32% Poorly correlated | -0.07% | ||
| THC - HCSG | 32% Poorly correlated | -1.17% | ||
| CON - HCSG | 31% Poorly correlated | +0.85% | ||
| GRDN - HCSG | 29% Poorly correlated | -6.90% | ||
More | ||||